Medios AG (MEDOF)
- Previous Close
0.00 - Open
13.64 - Bid 11.44 x 38800
- Ask 16.44 x 38500
- Day's Range
13.64 - 13.64 - 52 Week Range
13.64 - 50.00 - Volume
2,000 - Avg. Volume
0 - Market Cap (intraday)
1.275B - Beta (5Y Monthly) --
- PE Ratio (TTM)
73.53 - EPS (TTM)
0.68 - Earnings Date Aug 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
www.medios.ag472
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MEDOF
View More
Performance Overview: MEDOF
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDOF
View MoreValuation Measures
Market Cap
325.68M
Enterprise Value
473.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--